SVStarboard Value LP
Institutional investor · Portfolio as of Q1 2020
Top Holdings18 positions
GEN DIGITAL INC | 26.7M | $499M | 20.2% | $12.78 | +27.66% | 2 qtrssince 2019-Q4 | Unchanged 0 |
ADVANCE AUTO PARTS INC | 2.6M | $240.1M | 9.7% | $143.62 | -43.40% | 3 qtrssince 2019-Q3 | Unchanged 0 |
EBAY INC. | 7.9M | $238.1M | 9.7% | $33.14 | -18.42% | 3 qtrssince 2019-Q3 | Increased 67 |
CERNER CORP | 3.5M | $218.9M | 8.9% | — | — | 3 qtrssince 2019-Q3 | Decreased 0 |
COMMVAULT SYS INC | 4.6M | $186.9M | 7.6% | $40.48 | 0.00% | 1 qtr | New 97 |
AECOM | 6M | $178.4M | 7.2% | $36.08 | -21.50% | 3 qtrssince 2019-Q3 | Unchanged 0 |
BOX INC | 11.7M | $163.9M | 6.6% | $15.62 | -10.09% | 3 qtrssince 2019-Q3 | Increased 88 |
MERIT MED SYS INC | 4.8M | $151.3M | 6.1% | $31.25 | 0.00% | 1 qtr | New 97 |
GREEN DOT CORP | 5M | $125.9M | 5.1% | $25.39 | 0.00% | 1 qtr | New 96 |
GCP APPLIED TECHNOLOGIES | 6.5M | $116.4M | 4.7% | — | — | 3 qtrssince 2019-Q3 | Increased 70 |
MAGELLAN HEALTH INC | 2.4M | $114M | 4.6% | — | — | 3 qtrssince 2019-Q3 | Unchanged 0 |
PEDIATRIX MEDICAL GROUP INC | 7.9M | $91.8M | 3.7% | $19.58 | -40.56% | 2 qtrssince 2019-Q4 | Increased 91 |
ISHARES TR | 975,777 | $80M | 3.2% | $104.63 | -30.47% | 3 qtrssince 2019-Q3 | Unchanged 0 |
ACI WORLDWIDE INC | 1.4M | $34.8M | 1.4% | $24.15 | 0.00% | 1 qtr | New 69 |
RESIDEO TECHNOLOGIES INC | 2.6M | $12.7M | 0.5% | $3.37 | +142.15% | 1 qtr | New 58 |
COMSCORE INC | 3M | $8.4M | 0.3% | $97.30 | -52.52% | 3 qtrssince 2019-Q3 | Unchanged 0 |
ISHARES TR | 3.5M | $5.2M | 0.2% | — | — | — | Increased — |
ISHARES TR | 125,000 | $613,000 | 0.0% | — | — | — | Unchanged — |
Starboard Value LP manages $2.5B across 18 positions as of Q1 2020. Top holdings: GEN (20.2%), AAP (9.7%), EBAY (9.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4/5.0.
Added 5 new positions, exited 3, increased 4, trimmed 1. Top move: CVLT (NEW, conviction 97). Portfolio: $2.5B across 18 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR